SCHEMBL19567720

SCHEMBL19567720

c1ccc(C2(c3cccc(-c4ccc(N(c5ccc(-c6cccc7ccccc67)cc5)c5cccc6ccccc56)cc4)c3)c3ccccc3-c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA9 Q16790 2/20 0.39
CHRNB4 P30926 2/20 0.35
CHRNA3 P32297 2/20 0.35
CHRNA1 P02708 1/20 0.35
CHRNG P07510 1/20 0.35
CHRNB1 P11230 1/20 0.35
CHRNB2 P17787 1/20 0.35
SLC6A2 P23975 1/20 0.35
SLC6A4 P31645 1/20 0.35
CHRNA4 P43681 1/20 0.35
SLC6A3 Q01959 1/20 0.35
CHRND Q07001 1/20 0.35
MCL1 Q07820 1/20 0.32
ACMSD Q8TDX5 1/20 0.32
CHRNA7 P36544 1/20 0.32
SLC6A9 P48067 1/20 0.31
PPARG P37231 7/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18287528 0.99 CA12 (0.39) CA12CA1CA2CA9CHRNB4
SCHEMBL19567717 0.97 CA12 (0.33) CA12CA1CA2CA9CHRNB4
SCHEMBL22151211 0.96 CA12 (0.37) CA12CA1CA2CA9CHRNB4
SCHEMBL18287530 0.96 CA12 (0.34) CA12CA1CA2CA9CHRNB4
SCHEMBL22151233 0.95 CA12 (0.37) CA12CA1CA2CA9CHRNB4
SCHEMBL19978453 0.94 CA12 (0.36) CA12CA1CA2CA9CHRNB4
SCHEMBL19567721 0.93 CA12 (0.41) CA12CA1CA2CA9CHRNB4
SCHEMBL19567719 0.93 CA12 (0.41) CA12CA1CA2CA9CHRNB4
SCHEMBL19567731 0.93 CA12 (0.36) CA12CA1CA2CA9CHRNB4
SCHEMBL19567727 0.92 MCL1 (0.35) CA12CA1CA2CA9CHRNB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10593885-B2 Polycyclic compound and organic electroluminescence device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-17 US disclosed
US-20170324037-A1 POLYCYCLIC COMPOUND AND ORGANIC ELETROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-09 US disclosed
US-20170324037-A1 POLYCYCLIC COMPOUND AND ORGANIC ELETROLUMINESCENCE DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10593885-B2 Polycyclic compound and organic electroluminescence device including the same ARL1, AR, RIF1 CA12 2532/4885CA1 2824/4885CA2 1722/4885
US-20170324037-A1 POLYCYCLIC COMPOUND AND ORGANIC ELETROLUMINESCENCE DEVICE INCLUDING THE SAME AR, ARL1, ESR2 CA12 581/4885CA1 1246/4885CA2 1632/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.